Auxiliary partial orthotopic liver transplantation (APOLT) in selected noncirrhotic metabolic liver diseases (NCMLDs) is a viable alternative to orthotopic liver transplantation (OLT) as it supplements the function of the native liver with the missing functional protein. APOLT for NCMLD is not universally accepted due to concerns of increased technical complications and longterm graft atrophy. Review of a prospectively collected database of all pediatric patients (age ≤16 years) who underwent liver transplantation for NCMLD from August 2009 up to June 2017 was performed. Patients were divided into 2 groups: group 1 underwent APOLT and group 2 underwent OLT. In total, 18 OLTs and 12 APOLTs were performed for NCMLDs during the study period. There was no significant difference in the age and weight of the recipients in both groups. All APOLT patients needed intraoperative portal flow modulation. Intraoperative peak and end of surgery lactate were significantly higher in the OLT group, and cold ischemia time was longer in the APOLT group. There were no differences in postoperative liver function tests apart from higher peak international normalized ratio in the OLT group. The incidence of postoperative complications, duration of hospital stay, and 1-and 5-year survivals were similar in both groups. In conclusion, we present the largest series of APOLT for NCMLD. APOLT is a safe and effective alternative to OLT and may even be better than OLT due to lesser physiological stress and the smoother postoperative period for selected patients with NCMLD.
Patients and Methods
The study was conducted in accordance with the principles of the Declaration of Helsinki (2008) and good clinical practice guidelines. Approval from the institutional ethics committee was obtained. Informed consent was obtained from all donors and recipients (legal guardian when applicable), and their anonymity was preserved.
Review of a prospectively collected database of all pediatric patients (age ≤16 years) who underwent liver transplantation (LT) for metabolic liver disease (MLD) from the initiation of the program in August 2009 to June 2017 was performed. It was supplemented by inpatient and outpatient clinical records, along with subsidiary databases of radiological and endoscopic interventions. Patients who had undergone LT for NCMLD were divided into 2 groups: those who underwent APOLT (group 1) and those who underwent OLT (group 2) (Fig. 1) . Patients with a cirrhotic liver on explant histopathological examination were excluded from the study. APOLT performed for ALF were also excluded. Variables and outcomes of APOLT versus those of OLT for NCMLD during the same period were compared and analyzed.
Operative techniQUe
The technique of OLT for NCMLD involved standard inferior vena cava (IVC) preserving hepatectomy after complete portal vein (PV) and IVC clamping. The technique of APOLT for MLD has previously been described by us in detail. (1, 5, 6) Briefly, left-sided APOLT was preferred, unless the patient was over 50 kg and/or had an organic acidemia, wherein a right lobe APOLT was favored. A comparatively larger liver volume may be required in children with organic acidemia to avoid or mitigate a metabolic crisis in the immediate postoperative period. This ensured a safer hepatectomy in living donors or the use of pediatric-sized grafts from split deceased donors. Recipients underwent an extended left hepatectomy, including the middle hepatic vein and caudate lobe to provide sufficient space for the graft liver. Graft-to-recipient weight ratio (GRWR) was not a decisive factor because the patient has sufficient volume of native remnant liver. Complete PV or IVC clamping was not necessary during implantation. The liver grafts were implanted using the triangular cavostomy technique (for left lateral segment [LLS] grafts) or a piggyback technique (left lobe [LL] and right lobe grafts). The left hepatic vein of graft was anastomosed to the common left/middle hepatic vein orifice of the recipient. The graft left PV was anastomosed to the recipient left PV stump or directly to the side of the MPV as appropriate, avoiding a kink in its course. As described previously, the graft left hepatic artery (HA) Original article | 113 is anastomosed to the recipient common hepatic artery (CHA) after the latter's division proximal to the origin of gastroduodenal artery (GDA) to ensure arterial inflow to the recipient right HA through the pancreaticoduodenal arcade. (5) Biliary anastomosis was either duct-to-duct or a Roux-en-y hepaticojejunostomy depending on the size of the recipient left hepatic duct (LHD) stump and a tension-free anastomosis. As described previously, all patients undergoing APOLT for NCMLD had portal flow modulation using graded hemiportal banding, the aim being to ensure preferential portal flow to the graft and avoid the phenomenon of portal steal (Fig. 2) . (6) Follow-up of patients with APOLT included performing biannual Doppler ultrasounds to confirm In patients with ALF, portal modulation is not required because the graft portal pressure is lower than the native liver's portal pressure. (E) In patients with NCMLD, the graft portal pressure may be higher; in these cases, graded banding of the remnant liver PV is performed until the portal pressure of the remnant is higher than that of the graft. preferential graft portal perfusion. Volumetric computed tomography (CT) to quantify the graft and native liver volume was done every 6 months in the first year of follow-up and then as per clinical indication. Patients with recurrence of metabolic symptoms were evaluated with Doppler ultrasound, volumetric CT, and graft and native liver biopsy.
statistical analYsis
Continuous values were expressed as means ± standard deviations. Statistical analysis was performed using SPSS, version 20.0 (Chicago, IL) for Windows. Categorical variables were analyzed by chi-square test or Fisher's exact test, as appropriate. Continuous variables were analyzed by Student t test or the Mann-Whitney U test, as appropriate. The actuarial probabilities of survival in those who underwent APOLT and OLT were done by Kaplan-Meier method, and comparisons were made with a log-rank test. A P value <0.05 was considered statistically significant.
Results
Of a total of 92 LTs for MLD, 30 were for NCMLD in the pediatric population. Of these, 18 were OLTs and 12 APOLTs forming 0.5% of our overall (adult and pediatric LT) numbers. During the same period, 6 patients underwent APOLT for ALF, and they were excluded from the study. Follow-up ranged from 6 to 82 months (median = 27 months). Indications for APOLT were CNS-1 (n = 4), propionic acidemia (PA; n = 5), and citrullinemia (n = 3). Ten patients underwent living donor liver transplantation (LDLT) APOLT, whereas 2 underwent deceased donor liver transplantation (DDLT) split APOLT (Table 1 ). All patients underwent extended left hepatectomy and received left lateral grafts (n = 11) or LL grafts (n = 1). Indications for OLT were primary hyperoxaluria (PH) type 1 (n = 12), tyrosinemia (n = 2), PA (n = 1), CNS-1 (n = 1), Maple Syrup Urine Disease (MSUD; n = 1), and Wilson's disease with only neurological manifestations (n = 1). Four patients with PH underwent a combined liver-kidney transplant. Of the 8 who underwent OLT for tyrosinemia, 6 recipients had cirrhotic livers on explant histopathology and were excluded from the series. One patient each of CNS-1 and PA underwent OLT because they were <6 months of age. Another child with MSUD underwent OLT due to parental preference. On comparing demographic variables between the 2 groups, apart from age (OLT were older children), there was no significant difference in the type of transplant and weight of the recipient. Intraoperative peak lactate (4.8 ± 2 versus 2.8 ± 0.9; P = 0.03) and end of surgery lactate (4.3 ± 1.9 versus 2.5 ± 0.3; P = 0.03) were significantly higher in the OLT group. The cold ischemia time (CIT) was longer in the APOLT group (226 ± 265 versus 73 ± 25 minutes; P = 0.04). The total duration of surgery was similar between the groups, but this included 4 patients in the OLT group who had a combined liver and kidney transplant. There was 1 patient who had reperfusion syndrome (defined as 30% decrease in mean arterial pressure, lasting at least 1 minute within the first 5 minutes of reperfusion) (7) in the OLT group (Table 2) .
There were no intraoperative complications in both groups ( Table 3 ). The explanted liver from the MSUD Original article | 115 patient was used as a domino graft for a child with Wilson's disease. The resected left hemiliver from a PA child was used as an auxiliary graft for a child with CNS-1. There was no difference in the liver function tests between the 2 groups apart from a significantly elevated peak international normalized ratio (INR) in the OLT group (2 ± 0.5 versus 1.4 ± 0.3; P = 0.002). There were no differences in the postoperative complications (reintubation rate, relaparotomy, PV complications, and biliary complications), duration of hospital stay, and overall 1-and 5-year survival (log-rank test, P = 0.08; Table 4 ; Fig. 3 ). One child who underwent APOLT for PA developed early HA thrombosis, which was managed successfully with surgical revascularization.
All children received total parenteral nutrition for the first 3-5 days with 1 g/kg of body weight of protein until enteral feeds were started with close monitoring of serum ammonia and amino acid levels. Enteral protein supplements were gradually increased to an unrestricted diet over a period of 5 days with monitoring of ammonia. All children were on normal diet/standard formula intake by the 10th postoperative day. Facilitating oral intake was difficult in many children because they were on enteral tube feeds and were not used to the taste and texture of normal diet. The postoperative recovery was uneventful in all patients with CNS-1. Serum bilirubin levels normalized within 6 days after APOLT (range, 3-7 days), and none of the children required phototherapy after surgery.
Patient number 5 with PA developed recurrence of the symptoms and hyperammonemia during an episode of intercurrent illness, secondary to portal steal after 9 months (Table 1) . A segmental PV embolization of the native liver was performed to cause segmental atrophy of native liver and facilitate compensatory hypertrophy of the graft. This rapidly reversed the metabolic abnormality, and the child has remained asymptomatic without further episodes of decompensations with good graft function with 29 months of follow-up.
All children with PA and citrullinemia had metabolic cure of hyperammonemia and are on unrestricted diets. Carnitine supplementation was stopped in patient 1, which resulted in low serum free carnitine and elevated acyl carnitine levels, hence was restarted. All other children with PA were continued on carnitine and biotin supplementation. All 3 children with CNS-1 had serum citrulline levels of more than 2000 µmol/L before transplant, which was reduced to 300-800 µmol/L after transplant on NOTE: Data are given as n (%) or mean ± standard deviation.
a median follow-up of 20 months. CNS-1 patients continued to receive arginine supplementation. CNS-1 patients have normal bilirubin values without phototherapy. There were 2 mortalities in the OLT group (Fig. 3 ). One child with PA developed graft dysfunction and severe metabolic crisis in the early postoperative period. Another OLT recipient had a jejunal perforation with sepsis and succumbed on posttransplant day 26. At follow-up, the other 16 OLT recipients remain well with no metabolic decompensation.
Discussion
APOLT was initially offered for children with NCMLD with the hope that future development of less invasive therapies like gene therapy or hepatocyte transplantation would provide permanent therapeutic options in their adult life. (1, (8) (9) (10) It was argued that once gene therapy is clinically available, the native remnant liver can be treated and that these patients will be able to come off immunosuppression. Although advancements have been made in this regard, it might take some time before clinical realization of these therapies happen, leading to a dampening enthusiasm in APOLT. (11) (12) (13) There are, however, other merits to performing APOLT, apart from an immunosuppression-free life hinging on the likely success of gene therapy. APOLT gives the option of transplanting a smaller graft to replace the missing enzyme, as part of the patient's own liver is left in situ to support all other liver functions. Most of these patients, even older children and adults, will only require a LLS graft. This can be provided by a standard LLS split graft in the DDLT setting or a left lateral segmentectomy in the living donor setting. In the LDLT setting, LLS donation is a safer operation for the donor as compared with a right lobe or LL donation. Similarly, a classical split is much more straightforward for most centers and will leave the extended right lobe for an adult recipient. (1, 2, 9) Patients with NCMLD undergoing LT are characterized by the absence of portal hypertension and portosystemic collaterals. Caval and PV clamping in a noncirrhotic setting causes significant hemodynamic changes and bowel edema. APOLT, being a form of partial LT, does not require a complete PV and IVC clamping. In addition, the systemic reperfusion syndrome is minimal because of the small volume graft and a near-normally functioning native liver serving the patient throughout the operative period, improving intraoperative patient stability. (1, 9) This was evident Original article | 117 by a lower peak and end of surgery lactate in the APOLT group. The CIT was expectedly longer by 153 minutes (mean) in the APOLT group, due the added time required for recipient partial hepatectomy. This also included 2 APOLTs who received LLS from deceased donor split livers.
In the early postoperative period, the normally functioning native liver reduces the systemic effect of graft dysfunction, which gives the patient and the graft an opportunity to recover. Graft failure is also not an immediate threat to the patient's life as in the case of OLT.
(1) This is particularly advantageous in children with PA where graft dysfunction after OLT can precipitate severe metabolic stress and decompensation. (1, 9) One mortality in the OLT group was due to graft dysfunction leading to severe metabolic decompensation, a situation which may have been obviated if the child had received an APOLT.
Portal steal may be a major issue in APOLT for NCMLD. (1, 2, 6, 8, 14) It increases the risk of graft atrophy and recurrence of the original symptoms of the disease. Portal steal occurs because the native liver is structurally normal and has lower resistance to portal flow than the partial graft. Portal flow is preferentially directed to the native liver after reperfusion, resulting in relative graft ischemia. The problem may also occur in the long term during episodes of acute rejection, wherein the rejection induced stiffer graft shunts portal blood away from the graft. Techniques of managing portal steal have primarily focused on encouraging graft portal flow by either inflow modulation or outflow modulation of the native liver. Inflow modulation by narrowing the native PV was reported by Whitington et al. (15) Ligation of the native liver PV was recommended by Yabe et al. to prevent portal steal. (16) However, this technique deprives the native liver of any portal flow, precluding the possibility of future gene therapy interventions. Should late graft failure occur, it can also lead to severe portal hypertension. The technique of graded hemiportal banding has been reported by the senior author (M.R.). (6) Briefly, the aim is to narrow the PV to the native liver in a staged manner until the resistance to portal flow (measured as portal pressure) to the native liver is higher than the resistance to the graft, thus ensuring preferential portal flow (measured as flow velocity on Doppler) to the graft. Broering et al. described inducing venous congestion in part of the native remnant by proximal division of the middle hepatic vein as a way to ensure preferential graft portal inflow. However, this form of outflow modulation is uncontrolled and may cause congestion of segments 4, 5, and 8, leading to abdominal compartment syndrome. (17) There is, however, the need for longterm surveillance, allowing for an early diagnosis of portal steal, should it occur. In the event of a diagnosis of portal steal in the postoperative period or later, interventional radiological embolization of a segmental native PV will ensure an increased resistance and thereby reverse the steal. (1, 18) This was done in one of our patients with PA.
Data regarding longterm outcomes of APOLT for NCMLD are limited, partly due to the small number of patients undergoing the procedure. Sze et al. reported similar longterm outcomes for children undergoing APOLT for NCMLD (90% survival at 5 and 7 years) as compared with standard OLT. (19) Ours is the largest series of APOLT for NCMLD, analyzing shortterm and longterm outcomes. Other smaller series on APOLT for NCMLD include those by Kasahara et al. where outcomes were suboptimal and concerns of portal steal were paramount. (2, 14) The major limitation of our study is the small sample size, although this is the largest study analyzing APOLT for NCMLD in the pediatric population. The multiplicity of NCMLDs might have affected certain parameters in the analysis, eg, hyperoxaluria patients in the OLT group could have been an active determinant of high postoperative INR.
With increasing experience of LDLT and implantation of partial grafts along with a better understanding of portal hemodynamics and technical modifications, we have shown improved outcomes with APOLT. In an appropriately selected patient, the short-term and longterm outcomes of APOLT for NCMLD are comparable if not better than those of OLT.
In conclusion, we present the largest ever series of APOLT for NCMLD, looking at short-term and longterm outcomes. Our results confirm the safety and success of APOLT for selected cases of NCMLD. In the appropriately selected patient, it may even be better than OLT due to lesser physiological stress and a smoother postoperative period. 
